Memantine attenuates responses of spinothalamic tract cells to cutaneous stimulation in neuropathic monkeys

European Journal of Pain

Volumn 2, Issue 3, 1998, Pages 229-238

  Carlton, Susan M ^a   Rees, Huw ^a   Tsuruoka, Masayoshi ^a   Willis, William D ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DOSE RESPONSE; ELECTROPHYSIOLOGY; INTRATHECAL DRUG ADMINISTRATION; MALE; MECHANICAL STIMULATION; MICRODIALYSIS; MONKEY; NERVE LIGATION; NEUROPATHY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; SKIN STIMULATION; SPINAL CORD DORSAL HORN; SPINOTHALAMIC TRACT;

EID: 0031691817     PISSN: 10903801     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1090-3801(98)90019-2     Document Type: Article

References (49)

1. Aanonsen LM, Lei S, Wilcox GL. Excitatory amino acid receptors and nociceptive neurotransmission in the rat spinal cord. Pain 1990; 41: 309-321.
2. Ambrozi L, Danielcyzk W. Treatment of impaired cerebral function in psychogeriatric patients with memantine-results of a phase II double-blind study. Pharmacopsychiatry 1988; 21: 144-146.
3. Backonja M, Arndt G, Gombar KA, Check B, Zimmermann M. Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain 1994; 56: 51-57.
4. Bonica JJ. Causalgia and other reflex sympathetic dystrophies. In: J. J. Bonica, editor. The management of pain, Vol. 2. Philadelphia, PA: Lea and Febiger, 1990; 220-243.
5. Carlton SM, Hargett GL. Treatment with the NMDA antagonist memantine attenuates nociceptive responses to mechanical stimulation in neuropathic rats. Neurosci Letts 1995; 198: 115-118.
6. Carlton SM, Lekan HA, Kim SH, Chung JM. Behavioral manifestations of an experimental model for peripheral neuropathy produced by spinal nerve ligation in the primate. Pain 1994a; 56: 155-166.
7. Carlton SM, Rees H, Gondesen K, Tsuruoka M, Willis WD. Behavioral and electrophysiological effects of memantine in a primate model of peripheral neuropathy. Soc for Neurosci 1994b.
8. Chung JM, Surmeier DJ, Lee KH, Sorkin LS, Honda CN, Tsong Y, Willis WD. Classification of primate spinothalamic and somatosensory thalamic neurons base on cluster analysis. J Neurophysiol 1986; 56: 308-327.
9. Coderre TJ, Melzack R. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 1992; 12: 3665-3670.
10. Davar G, Hama A, Deykin A, Vos B, Maciewicz R. MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy. Brain Res 1991; 553: 327-330.
11. Dickenson AH. A cure for wind up: NMDA receptor antagonists as potential analgesics. Trends Pharmacol Sci 1990; 11: 307-309.
12. Dougherty PM, Palecek J, Paleckova V, Sorkin LS, Willis WD. The role of NMDA and non-NMDA excitatory amino acid receptors in the excitation of primate spinothalamic tract neurons by mechanical, chemical, thermal, and electrical stimuli. J Neurosci 1992; 12: 3025-3041.
13. Eide PK, Jorum E, Stubhaug A, Bremnes J, Breivik H. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain 1994; 58: 347-354.
14. Eide PK, Stubhaug A, Oye I, Breivik H. Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia. Pain 1995; 61: 221-228.
15. Eisenberg E, LaCross S, Strassman AM. The clinically tested N-methyl-D-aspartate receptor antagonist memantine blocks and reverses thermal hyperalgesia in a rat model of painful mononeuropathy. Neurosci Letts 1995; 187: 17-20.
16. Erdo SL, Schafer M. Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartate. Eur J Pharmacol 1991; 198: 215-217.
17. Furuyama T, Kiyama H, Sato K, Park HT, Maeno H, Takagi H, Tohyama M. Region-specific expression of subunits of ionotropic glutamate receptors (AMPA-type, KA-type and NMDA receptors) in the rat spinal cord with special reference to nociception. Mol Brain Res 1993; 18: 141-151.
18. Haley J, Sullivan AF, Dickenson AH. Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res 1990; 518: 218-226.
19. Herrero JF, Headley PM, Parsons CG. Memantine selectively depresses NMDA receptor-mediated responses of rat spinal neurones in vivo. Neurosci Letts 1994; 165: 37-40.
20. Klepstad P, Maurset A, Moberg ER, Oye I. Evidence of a role for NMDA receptors in pain perception. Eur J Pharmacol 1990; 187: 513-518.
21. Kristensen JD, Svensson B, Gordh T. The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans. Pain 1992; 51: 249-253.
22. Liu H, Wang H, Sheng M, Jan LY, Jan YN, Basbaum AI. Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn. Proc Natl Acad Sci 1994; 91: 8383-8387.
23. Mao J, Price DD, Hayes RL, Lu J, Mayer DJ. Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy. Brain Res 1992a; 598: 271-278.
24. Mao J, Price DD, Hayes RL, Lu J, Mayer DJ, Frenk H. Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy. Brain Res 1993; 605: 164- 168.
25. Mao J, Price DD, Mayer DJ, Lu J, Hayes RL. Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy. Brain Res 1992b; 576: 254-262.
26. Mathisen LC, Skjelbred P, Skoglund LA, Oye I. Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain. Pain 1995; 61: 215-220.
27. Maurset A, Skoglund LA, Hustveit O, Oye I. Comparison of ketamine and pethidine in experimental and postoperative pain. Pain 1989; 36: 37-41.
28. Max MB, Byas-Smith MG, Gracely RH, Bennett GJ. Intravenous infusion of the NMDA antagonist, ketamin, in chronic posttraumatic pain with allodynia: a double-blind comparison to alfentanil and placebo. Clin Neuropharmacol 1995; 18: 360-368.
29. Mitchell SW. Injuries of nerves and their consequences. Philadelphia, PA: Lippincott, 1872.
30. Nelson KA, Park KM, Robinovitz E, Max MB. High-dose oral dextromethorphn versus placebo in painful diabetic neuropthy and postherpetic neuralgia. Neurology 1997; 48: 1212-1218.
31. Neugebauer V, Kornhuber J, Lucke T, Schaible H-G. The clinically available NMDA receptor antagonist memantine is antinociceptive on rat spinal neurones. Neuro Report 1993; 4: 1259-1262.
32. Neugebauer V, Lucke T, Grubb B, Schaible H-G. The involvement of N-methyl-D-aspartate (NMDA) and non-NMDA receptors in the responsiveness of rat spinal neurons with input from the chronically inflamed ankle. Neurosci Letts 1994; 170: 237-240.
33. Owens CM, Zhang D, Willis WD. Changes in the response states of primate spinothalamic tract cells caused by mechanical damage of the skin or activation of descending controls. J Neurophysiol 1992; 67: 1509-1527.
34. Palecek J, Dougherty PM, Kim SH, Paleckova V, Lekan H, Chung JM, Carlton SM, Willis WD. Responses of spinothalamic tract neurons to mechanical and thermal stimuli in an experimental model of peripheral neuropathy in primates. J Neurophysiol 1992; 68: 1951-1966.
35. Park KM, Max MB, Robinovitz E, Gracely RH, Bennett GJ. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects. Pain 1995; 63: 163-172.
36. Persson J, Axelsson G, Hallin RG, Gustafsson LL. Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitization. Pain 1995; 60: 217-222.
37. Petralia RS, Yokotani N, Wenthold RJ. Light and electron microscope distribution of the NMDA receptor subunit NMDAR1 in the rat nervous system using a selective anti-peptide antibody. J Neurosci 1994; 14: 667-696.
38. Qian J, Brown S, Carlton SM. Systemic ketamine attenuates nociceptive behaviors in a rat model of peripheral neuropathy. Brain Res 1996; 715: 51-62.
39. Rabey JM, Nissipeanu P, Korczyn AD. Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease. J Neural Trans 1992; 4: 277-282.
40. Ren K, Hylden JLK, Williams GM, Ruda MA, Dubner R. The effects of a non-competitive NMDA receptor antagonist, MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation. Pain 1992; 50: 331-344.
41. Richards RL. Causalgia. Arch Neurol 1967; 16: 339-350.
42. Sluka KA, Westlund KN. Spinal cord amino acid release and content in an arthritis model: the effects of pretreatment with non-NMDA, NMDA, and NK1 receptor antagonists. Brain Res 1993; 627: 89-103.
43. Stannard CF, Porter GE. Ketamine hydrochloride in the treatment of phantom limb pain. Pain 1993; 54: 227-230.
44. Tal M, Bennett GJ. Dextrorphan relieves neuropathic heatevoked hyperalgesia in the rat. Neurosci Lett 1993; 151: 107-110.
45. Wesemann W, Schollmeyer JD, Sturm G. Distribution of memantine in brain, liver, and blood of the rat. Arzneim-Forschl Drug Res 1982; 32: 1243-1245.
46. Wilcox GL, Giesler GJ. An instrument using a multiple layer peltier device to change skin temperature rapidly. Brain Res Bull 1984; 12: 143-146.
47. Willis WD, Coggeshall RE. Sensory Mechanisms of the Spinal Cord. 2nd edition. New York, NY: Plenum Press, 1991.
48. Woolf CJ, Thompson SWN. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartate acid receptor activation; implications for treatment of post-injury pain hypersensitivity states. Pain 1991; 44: 293-299.
49. Zimmermann M. Ethical guidelines for investigations of experimental pain in consious animals. Pain 1983; 16: 109-110.